Home › All Companies › ASTH › Annual Report

Astrana Health, Inc. (ASTH) — Annual Report

AI-Powered SEC Filing Analysis

← All ASTH filings
Latest Annual Report Filed: 2026-03-12

Key Insights

  • The company has significant investments in related party entities, including Collaborative Health Systems LLC, Apollo Sun Labs Management LLC, and Advanced Diagnostic and Surgical Center Inc., which could pose potential conflicts of interest and risks.
  • Astrana Health has a revolving credit facility and term loans that expose the company to interest rate risk, with the maximum interest rate on the loans reaching over 25% as of the most recent filing.
  • The company's revenue is heavily concentrated in a few major payors, with Payor A and Payor C accounting for a significant portion of accounts receivable, indicating potential customer concentration risk.
Sentiment: Negative Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Astrana Health, Inc.

Quarterly Report Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.